SARS-CoV-2 Main Protease Inhibitor High-Throughput Screen

被引：0
作者：
Delgado, Renee [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX USA
来源：
JOURNAL OF BIOLOGICAL CHEMISTRY | 2024年 / 300卷 / 03期
关键词：
Mpro (main protease); high-throughput screening; drug discovery; SARS-CoV-2;
D O I：
10.1016/j.jbc.2024.106070
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
1217
引用
收藏
页码：S172 / S172
页数：1
相关论文
共 50 条
  • [21] SARS-CoV-2 RNA-dependent RNA polymerase as a target for high-throughput drug screening
    Wu, Jiahui
    Chen, Zhiqiang
    Han, Xue
    Chen, Qiaoqiao
    Wang, Yintao
    Feng, Tingting
    [J]. FUTURE VIROLOGY, 2023, : 51 - 62
  • [22] High-throughput screening assays for SARS-CoV-2 drug development: Current status and future directions
    Xu, Tuan
    Zheng, Wei
    Huang, Ruili
    [J]. DRUG DISCOVERY TODAY, 2021, 26 (10) : 2439 - 2444
  • [23] Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors
    Cardoso, Wesley B.
    Mendanha, Sebastiao A.
    [J]. JOURNAL OF MOLECULAR STRUCTURE, 2021, 1225
  • [24] Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screening
    Sanachai, Kamonpan
    Somboon, Tuanjai
    Wilasluck, Patcharin
    Deetanya, Peerapon
    Wolschann, Peter
    Langer, Thierry
    Lee, Vannajan Sanghiran
    Wangkanont, Kittikhun
    Rungrotmongkol, Thanyada
    Hannongbua, Supot
    [J]. PLOS ONE, 2022, 17 (06):
  • [25] Microbial Natural Products as Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro)
    Sayed, Ahmed M.
    Alhadrami, Hani A.
    El-Gendy, Ahmed O.
    Shamikh, Yara, I
    Belbahri, Lassaad
    Hassan, Hossam M.
    Abdelmohsen, Usama Ramadan
    Rateb, Mostafa E.
    [J]. MICROORGANISMS, 2020, 8 (07) : 1 - 17
  • [26] Ensemble docking based virtual screening of SARS-CoV-2 main protease inhibitors
    Fomina, Anastasia D.
    Uvarova, Victoria I.
    Kozlovskaya, Liubov I.
    Palyulin, Vladimir A.
    Osolodkin, Dmitry I.
    Ishmukhametov, Aydar A.
    [J]. MOLECULAR INFORMATICS, 2024, 43 (08)
  • [27] Fragment-based in silico design of SARS-CoV-2 main protease inhibitors
    Ahmad, Sarfraz
    Mirza, Muhammad Usman
    Kee, Lee Yean
    Nazir, Mamoona
    Rahman, Noorsaadah Abdul
    Trant, John F.
    Abdullah, Iskandar
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2021, 98 (04) : 604 - 619
  • [28] Fenoterol and dobutamine as SARS-CoV-2 main protease inhibitors: A virtual screening study
    Bolelli, Kayhan
    Ertan-Bolelli, Tugba
    Unsalan, Ozan
    Altunayar-Unsalan, Cisem
    [J]. JOURNAL OF MOLECULAR STRUCTURE, 2021, 1228 (1228)
  • [29] Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study
    Refaey, Rana H.
    El-Ashrey, Mohamed K.
    Nissan, Yassin M.
    [J]. VIROLOGY, 2021, 554 : 48 - 54
  • [30] An ISG15-Based High-Throughput Screening Assay for Identification and Characterization of SARS-CoV-2 Inhibitors Targeting Papain-like Protease
    Samrat, Subodh Kumar
    Kumar, Prashant
    Liu, Yuchen
    Chen, Ke
    Lee, Hyun
    Li, Zhong
    Chen, Yin
    Li, Hongmin
    [J]. VIRUSES-BASEL, 2024, 16 (08):
12345